## Abstract ## Background Mesenchymal stem cells (MSCs) have drawn considerable attention as vehicles for cellβ or geneβbased therapies, yet various problems still exist for current gene delivery vectors. On the other hand, baculovirus has emerged as a novel gene therapy vector, but its transducti
Human Mesenchymal Stem Cells Maintain Transgene Expression during Expansion and Differentiation
β Scribed by Lee, K
- Book ID
- 120522301
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 376 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1525-0016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Availability of human chondrocytes is a major limiting factor regarding drug discovery projects and tissue replacement therapies. As an alternative human mesenchymal stem cells (hMSCs) from bone marrow are taken into consideration as they can differentiate along the chondrogenic lineage
## Abstract ## Background The ability of human mesenchymal stem cells (hMSCs) to differentiate into specific cells holds promise for therapeutic use in cellβ or geneβbased therapy. Genetic modification of hMSCs by introduction of therapeutic genes is an important tool for successful cellβmediated
## Abstract Human mesenchymal stem cells (MSCs) reside under hypoxic conditions in vivo, between 4% and 7% oxygen. Differentiation of MSCs under hypoxic conditions results in inhibited osteogenesis, while chondrogenesis is unaffected. The reasons for these results may be associated with the inheren